Litcius/Paper detail

PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology

Tereza Altschmiedová, Veronika Todorovová, Michaela Šnejdrlová, M. Šatný, R Češka

2022Current Atherosclerosis Reports20 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePCSK9AngiologyRandomized controlled trialClinical trialAtherosclerotic cardiovascular diseaseInternal medicineDiseaseIntensive care medicineCholesterolLipoproteinLDL receptorLipoproteins and Cardiovascular HealthPharmaceutical Economics and Policy
PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology | Litcius